NCT07597382Completed
A Study of NatureU Burn on Satiety in Healthy Adults
A Single-Center, Single-Blind, Non-Randomized Crossover Exploratory Study of NatureU Burn With Glucose on Postprandial Satiety in Healthy Adults
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
This single-center, single-blind, non-randomized crossover exploratory study evaluated the short-term effects of NatureU Burn on postprandial satiety in healthy adults. NatureU Burn is an oral dietary supplement containing Irvingia gabonensis seed extract and high-molecular-weight inulin. Fourteen healthy adults were enrolled, and 12 participants completed the study and were included in the effectiveness analysis. Each participant completed two test sessions separated by at least 48 hours: a reference food session with 75 g medical anhydrous glucose in 250 mL warm purified water and a test food session with one capsule of NatureU Burn plus 75 g glucose in 250 mL warm purified water. Satiety-related questionnaire scores were assessed at fasting baseline and at 30, 60, 90, 120, 180, and 240 minutes after the first bite in each session. The study assessed fullness, hunger, desire for food, and prospective food consumption, and monitored adverse reactions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 11 May 2026
- Start date
- 22 Apr 2024
- Primary completion date
- 26 Apr 2024
- Lead sponsor
- OmniSolutions Laboratory Holdings Limited
- Diseases
- Obesity
- NCT number
- NCT07597382
What you commit to
- Study type: Interventional
- Participants enrolled: 14
- From 22 Apr 2024 to the primary completion date, 26 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Chronic sleep deprivation during the previous 3 months.
- Self-reported body weight increase or decrease of at least 4 kg during the previous 3 months.
- Current use of weight-loss medications.
- Major surgery or hospitalization within the previous 3 months.
Other illness
- History of bariatric surgery.
- Eating disorders, including binge eating disorder, anorexia nervosa, or bulimia nervosa.
- Intolerance or allergy to the test foods.
Lab values
- Abnormal glucose metabolism or lipid metabolism.
Other
- Pregnant or breastfeeding women.
- Individuals engaged in heavy physical labor or high-intensity exercise.
- Special dietary patterns, such as low-carbohydrate diet or intermittent fasting.
- Abnormal eating attitude based on eating attitude assessment.
- Serious cardiovascular, hepatic, renal, gastrointestinal, hematologic, or neurologic dysfunction.
- Excessive smoking, defined as more than 15 cigarettes per day.
- Alcohol consumption greater than 15 g alcohol per day.
Who the study is looking for
- Healthy adults aged 18 to 50 years.
- Male or female participants.
- Body mass index within the normal range of 18.5 to 23.9 kg/m2.
- Regular habit of eating breakfast.
- Able to fast for at least 10 hours after dinner.
- Signed informed consent before enrollment.
Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dao County People's Hospital Coordinator of this site? Confirm its status | Yongzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.